Logo image of MELE.BR

MELEXIS NV (MELE.BR) Stock Fundamental Analysis

Europe - EBR:MELE - BE0165385973 - Common Stock

55.65 EUR
-0.65 (-1.15%)
Last: 11/14/2025, 7:00:00 PM
Fundamental Rating

6

Taking everything into account, MELE scores 6 out of 10 in our fundamental rating. MELE was compared to 62 industry peers in the Semiconductors & Semiconductor Equipment industry. MELE has an excellent profitability rating, but there are some minor concerns on its financial health. MELE has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

MELE had positive earnings in the past year.
MELE had a positive operating cash flow in the past year.
In the past 5 years MELE has always been profitable.
In the past 5 years MELE always reported a positive cash flow from operatings.
MELE.BR Yearly Net Income VS EBIT VS OCF VS FCFMELE.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

Looking at the Return On Assets, with a value of 14.20%, MELE belongs to the top of the industry, outperforming 80.65% of the companies in the same industry.
MELE has a better Return On Equity (25.94%) than 79.03% of its industry peers.
With a decent Return On Invested Capital value of 15.69%, MELE is doing good in the industry, outperforming 77.42% of the companies in the same industry.
MELE had an Average Return On Invested Capital over the past 3 years of 31.03%. This is significantly above the industry average of 14.29%.
The 3 year average ROIC (31.03%) for MELE is well above the current ROIC(15.69%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 14.2%
ROE 25.94%
ROIC 15.69%
ROA(3y)25.78%
ROA(5y)24.35%
ROE(3y)36.37%
ROE(5y)32.97%
ROIC(3y)31.03%
ROIC(5y)28.48%
MELE.BR Yearly ROA, ROE, ROICMELE.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

1.3 Margins

With a Profit Margin value of 15.42%, MELE perfoms like the industry average, outperforming 59.68% of the companies in the same industry.
In the last couple of years the Profit Margin of MELE has grown nicely.
The Operating Margin of MELE (18.29%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of MELE has grown nicely.
The Gross Margin of MELE (40.24%) is worse than 64.52% of its industry peers.
MELE's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 18.29%
PM (TTM) 15.42%
GM 40.24%
OM growth 3Y0.51%
OM growth 5Y8.98%
PM growth 3Y-3.36%
PM growth 5Y8.23%
GM growth 3Y0.09%
GM growth 5Y1.54%
MELE.BR Yearly Profit, Operating, Gross MarginsMELE.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MELE is creating value.
Compared to 1 year ago, MELE has about the same amount of shares outstanding.
The number of shares outstanding for MELE has been increased compared to 5 years ago.
MELE has a worse debt/assets ratio than last year.
MELE.BR Yearly Shares OutstandingMELE.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
MELE.BR Yearly Total Debt VS Total AssetsMELE.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

MELE has an Altman-Z score of 6.14. This indicates that MELE is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of MELE (6.14) is comparable to the rest of the industry.
The Debt to FCF ratio of MELE is 3.48, which is a good value as it means it would take MELE, 3.48 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of MELE (3.48) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.62 indicates that MELE is somewhat dependend on debt financing.
The Debt to Equity ratio of MELE (0.62) is worse than 75.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 3.48
Altman-Z 6.14
ROIC/WACC1.48
WACC10.57%
MELE.BR Yearly LT Debt VS Equity VS FCFMELE.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

MELE has a Current Ratio of 5.59. This indicates that MELE is financially healthy and has no problem in meeting its short term obligations.
MELE's Current ratio of 5.59 is amongst the best of the industry. MELE outperforms 91.94% of its industry peers.
A Quick Ratio of 2.71 indicates that MELE has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.71, MELE belongs to the top of the industry, outperforming 82.26% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.59
Quick Ratio 2.71
MELE.BR Yearly Current Assets VS Current LiabilitesMELE.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

4

3. Growth

3.1 Past

The earnings per share for MELE have decreased strongly by -46.51% in the last year.
The Earnings Per Share has been growing by 23.04% on average over the past years. This is a very strong growth
MELE shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.57%.
The Revenue has been growing by 13.89% on average over the past years. This is quite good.
EPS 1Y (TTM)-46.51%
EPS 3Y9.29%
EPS 5Y23.04%
EPS Q2Q%-46.03%
Revenue 1Y (TTM)-16.57%
Revenue growth 3Y13.16%
Revenue growth 5Y13.89%
Sales Q2Q%-13.14%

3.2 Future

The Earnings Per Share is expected to grow by 10.45% on average over the next years. This is quite good.
The Revenue is expected to grow by 5.56% on average over the next years.
EPS Next Y-29.5%
EPS Next 2Y-6.32%
EPS Next 3Y2.1%
EPS Next 5Y10.45%
Revenue Next Year-10.45%
Revenue Next 2Y-0.74%
Revenue Next 3Y2.62%
Revenue Next 5Y5.56%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MELE.BR Yearly Revenue VS EstimatesMELE.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B
MELE.BR Yearly EPS VS EstimatesMELE.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2 4 6

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 20.76 indicates a rather expensive valuation of MELE.
Compared to the rest of the industry, the Price/Earnings ratio of MELE indicates a somewhat cheap valuation: MELE is cheaper than 74.19% of the companies listed in the same industry.
MELE is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 25.89, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 14.99, MELE is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MELE indicates a rather cheap valuation: MELE is cheaper than 82.26% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 34.59, MELE is valued rather cheaply.
Industry RankSector Rank
PE 20.76
Fwd PE 14.99
MELE.BR Price Earnings VS Forward Price EarningsMELE.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

MELE's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. MELE is cheaper than 70.97% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MELE indicates a rather cheap valuation: MELE is cheaper than 83.87% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 24.32
EV/EBITDA 12.36
MELE.BR Per share dataMELE.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

MELE has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.9
EPS Next 2Y-6.32%
EPS Next 3Y2.1%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.27%, MELE has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 1.31, MELE pays a better dividend. On top of this MELE pays more dividend than 90.32% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.36, MELE has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.27%

5.2 History

On average, the dividend of MELE grows each year by 10.98%, which is quite nice.
Dividend Growth(5Y)10.98%
Div Incr Years3
Div Non Decr Years6
MELE.BR Yearly Dividends per shareMELE.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3

5.3 Sustainability

MELE pays out 112.64% of its income as dividend. This is not a sustainable payout ratio.
The dividend of MELE is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP112.64%
EPS Next 2Y-6.32%
EPS Next 3Y2.1%
MELE.BR Yearly Income VS Free CF VS DividendMELE.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M
MELE.BR Dividend Payout.MELE.BR Dividend Payout, showing the Payout Ratio.MELE.BR Dividend Payout.PayoutRetained Earnings

MELEXIS NV

EBR:MELE (11/14/2025, 7:00:00 PM)

55.65

-0.65 (-1.15%)

Chartmill FA Rating
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)10-29 2025-10-29/bmo
Earnings (Next)02-04 2026-02-04/amc
Inst Owners16.58%
Inst Owner ChangeN/A
Ins Owners25%
Ins Owner ChangeN/A
Market Cap2.25B
Revenue(TTM)822.53M
Net Income(TTM)131.83M
Analysts76.67
Price Target76.84 (38.08%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.27%
Yearly Dividend3.7
Dividend Growth(5Y)10.98%
DP112.64%
Div Incr Years3
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)19.96%
Min EPS beat(2)-2.47%
Max EPS beat(2)42.38%
EPS beat(4)1
Avg EPS beat(4)-0.06%
Min EPS beat(4)-38.45%
Max EPS beat(4)42.38%
EPS beat(8)3
Avg EPS beat(8)-0.67%
EPS beat(12)6
Avg EPS beat(12)0.27%
EPS beat(16)10
Avg EPS beat(16)4.23%
Revenue beat(2)1
Avg Revenue beat(2)0.71%
Min Revenue beat(2)-1.87%
Max Revenue beat(2)3.28%
Revenue beat(4)1
Avg Revenue beat(4)-1.66%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)3.28%
Revenue beat(8)1
Avg Revenue beat(8)-1.74%
Revenue beat(12)3
Avg Revenue beat(12)-1.22%
Revenue beat(16)6
Avg Revenue beat(16)-0.6%
PT rev (1m)-0.64%
PT rev (3m)1.37%
EPS NQ rev (1m)1.46%
EPS NQ rev (3m)-14.43%
EPS NY rev (1m)-0.32%
EPS NY rev (3m)-5.22%
Revenue NQ rev (1m)0.75%
Revenue NQ rev (3m)-1.1%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)1.11%
Valuation
Industry RankSector Rank
PE 20.76
Fwd PE 14.99
P/S 2.63
P/FCF 24.32
P/OCF 17.05
P/B 4.42
P/tB 4.44
EV/EBITDA 12.36
EPS(TTM)2.68
EY4.82%
EPS(NY)3.71
Fwd EY6.67%
FCF(TTM)2.29
FCFY4.11%
OCF(TTM)3.26
OCFY5.87%
SpS21.17
BVpS12.58
TBVpS12.55
PEG (NY)N/A
PEG (5Y)0.9
Graham Number27.54
Profitability
Industry RankSector Rank
ROA 14.2%
ROE 25.94%
ROCE 18.88%
ROIC 15.69%
ROICexc 16.36%
ROICexgc 16.39%
OM 18.29%
PM (TTM) 15.42%
GM 40.24%
FCFM 10.81%
ROA(3y)25.78%
ROA(5y)24.35%
ROE(3y)36.37%
ROE(5y)32.97%
ROIC(3y)31.03%
ROIC(5y)28.48%
ROICexc(3y)38.83%
ROICexc(5y)36.08%
ROICexgc(3y)39.06%
ROICexgc(5y)36.42%
ROCE(3y)37.33%
ROCE(5y)34.27%
ROICexgc growth 3Y-14.81%
ROICexgc growth 5Y1.87%
ROICexc growth 3Y-14.47%
ROICexc growth 5Y2.21%
OM growth 3Y0.51%
OM growth 5Y8.98%
PM growth 3Y-3.36%
PM growth 5Y8.23%
GM growth 3Y0.09%
GM growth 5Y1.54%
F-Score4
Asset Turnover0.92
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF 3.48
Debt/EBITDA 1.52
Cap/Depr 77.5%
Cap/Sales 4.61%
Interest Coverage 14.77
Cash Conversion 63.61%
Profit Quality 70.12%
Current Ratio 5.59
Quick Ratio 2.71
Altman-Z 6.14
F-Score4
WACC10.57%
ROIC/WACC1.48
Cap/Depr(3y)136.47%
Cap/Depr(5y)110.04%
Cap/Sales(3y)6.76%
Cap/Sales(5y)6.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-46.51%
EPS 3Y9.29%
EPS 5Y23.04%
EPS Q2Q%-46.03%
EPS Next Y-29.5%
EPS Next 2Y-6.32%
EPS Next 3Y2.1%
EPS Next 5Y10.45%
Revenue 1Y (TTM)-16.57%
Revenue growth 3Y13.16%
Revenue growth 5Y13.89%
Sales Q2Q%-13.14%
Revenue Next Year-10.45%
Revenue Next 2Y-0.74%
Revenue Next 3Y2.62%
Revenue Next 5Y5.56%
EBIT growth 1Y-40.01%
EBIT growth 3Y13.74%
EBIT growth 5Y24.11%
EBIT Next Year-17.12%
EBIT Next 3Y7.11%
EBIT Next 5Y7.45%
FCF growth 1Y533.33%
FCF growth 3Y6.64%
FCF growth 5Y13.04%
OCF growth 1Y213.78%
OCF growth 3Y7.8%
OCF growth 5Y13.55%

MELEXIS NV / MELE.BR FAQ

What is the ChartMill fundamental rating of MELEXIS NV (MELE.BR) stock?

ChartMill assigns a fundamental rating of 6 / 10 to MELE.BR.


What is the valuation status for MELE stock?

ChartMill assigns a valuation rating of 5 / 10 to MELEXIS NV (MELE.BR). This can be considered as Fairly Valued.


How profitable is MELEXIS NV (MELE.BR) stock?

MELEXIS NV (MELE.BR) has a profitability rating of 7 / 10.


What is the financial health of MELEXIS NV (MELE.BR) stock?

The financial health rating of MELEXIS NV (MELE.BR) is 6 / 10.


Can you provide the dividend sustainability for MELE stock?

The dividend rating of MELEXIS NV (MELE.BR) is 4 / 10 and the dividend payout ratio is 112.64%.